Further discussion on the association between desmoglein 2 and tumor size of non-small cell lung cancer-Reference-Cited by-同舟云学术

Further discussion on the association between desmoglein 2 and tumor size of non-small cell lung cancer

Published:2020-11-22 Issue:2 Volume:147 Page:633-635
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Hao Siyuan,Liu Jiayi,Ma Jia^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00432-020-03465-7.pdf

Reference15 articles.

1. Cai F, Zhu QQ, Miao YY, Shen SM, Su X, Shi Y (2017a) Desmoglein-2 is overexpressed in non-small cell lung cancer tissues and its knockdown suppresses NSCLC growth by regulation of p27 and CDK2. J Cancer Res Clin Oncol 143:59–69. https://doi.org/10.1007/s00432-016-2250-0

2. Cai F, Zhu Q, Miao Y, Shen S, Su X, Shi Y (2017b) Desmoglein-2 is overexpressed in non-small cell lung cancer tissues and its knockdown suppresses NSCLC growth by regulation of p27 and CDK2. J Cancer Res Clin Oncol 143:59–69. https://doi.org/10.1007/s00432-016-2250-0

3. Chen SS et al (2020) Stem signatures associated antibodies yield early diagnosis and precise prognosis predication of patients with non-small cell lung cancer. J Cancer Res Clin Oncol. https://doi.org/10.1007/s00432-020-03325-4

4. Du TQ, Li X, Zhong WS, Tian JD, Zhao YX, Liu D (2020) Brain metastases of lung cancer: comparison of survival outcomes among whole-brain radiotherapy, whole-brain radiotherapy with consecutive boost, and simultaneous integrated boost. J Cancer Res Clin Oncol. https://doi.org/10.1007/s00432-020-03359-8

5. Han CP, Yu YH, Wang AG, Tian Y, Zhang HT, Zheng ZM, Liu YS (2018) Desmoglein-2 overexpression predicts poor prognosis in hepatocellular carcinoma patients. Eur Rev Med Pharmacol Sci 22:5481–5489

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The prognostic and clinicopathological significance of desmoglein 2 in human cancers: a systematic review and meta-analysis;PeerJ;2022-03-22